← Open Payments lookup

KELLY COLEMAN: Open Payments

NPI 1801907746 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,103 in 42 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $796 · 2025 $1,103

Food & beverage: $1,074Education: $29
CompanyPaymentsAmount
Janssen Biotech, Inc.10$445
ABBVIE INC.12$186
Madrigal Pharmaceuticals3$179
Takeda Pharmaceuticals U.S.A., Inc.5$106
Phathom Pharmaceuticals, Inc.3$49
Lilly USA, LLC2$36
Gilead Sciences, Inc.2$35
Janssen Pharmaceuticals, Inc3$29
Regeneron Healthcare Solutions, Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: TREMFYA, REZDIFFRA, LINZESS, EOHILIA, ENTYVIO, VOQUEZNA, RINVOQ, DUPIXENT.

Industry payments across NY — which companies pay providers there.